Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness

Molecular Endocrinology

Volumn 15, Issue 6, 2001, Pages 972-984

  Shinozaki, Hiromitsu ^a   Fanelli, Francesca ^b   Liu, Xuebo ^a   Jaquette, Julie ^a   Nakamura, Kazuto ^a   Segaloff, Deborah L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; CYCLIC AMP; INOSITOL PHOSPHATE; LEUCINE; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; PROTEIN KINASE C;

AMINO ACID SUBSTITUTION; ARTICLE; CELL CULTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

EID: 0034982278     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.6.0661     Document Type: Article

References (57)

1. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
2. Lutropin-choriogonadotropin receptor: An unusual member of the G protein-coupled receptor family
3. Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven transmembrane region
4. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats
5. The leucine-rich repeat: A versatile binding motif
6. Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity
7. Intronic nature of the rat luteinizing hormone receptor gene defines a soluble receptor subspecies with hormone binding activity
8. Leutropin/b-adrenergic receptor chimeras bind choriogonadotropin and adrenergic ligands but are not expressed at the cell surface
9. Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity
10. Exons 1-10 of the rat LH receptor encode a high affinity hormone binding site and exon 11 encodes G-protein modulation and a potential second hormone binding site
11. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function
12. Derivation of functional antagonists using N-terminal extracellular domain of gonadotropin and thyrotropin receptors
13. Differential roles of exoloop 1 of the human follicle-stimulating hormone receptor in hormone binding and receptor activation
14. Exoloop 3 of the luteinizing hormone/choriogonadotropin receptor
15. Lys-583 in the third extracellular loop of the lutropin/choriogonadotropin receptor is critical for signaling
16. Luteinizing hormone/choriogonadotropin receptor-mediated activation of heterotrimeric guanine nucleotide binding proteins in ovarian follicular membranes
17. Luteinizing hormone/choriogonadotropin-dependent, cholera toxin-catalyzed adenosine 5′-diphosphate (ADP)-ribosylation of the long and short forms of Gsα and pertussis toxin-catalyzed ADP-ribosylation of Giα
18. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca+2 mobilization
19. Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization, and enhance agonist-induced receptor down-regulation
20. Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C
21. Naturally occurring mutations of the luteinizing-hormone receptor: Lessons learned about reproductive physiology and G protein-coupled receptors
22. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: A novel constitutively activating mutation in the first transmembrane helix
23. Evidence for the direct involvement of transmembrane region six of the lutropin/choriogonadotropin receptor in activating Gs
24. Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs
25. A unique constitutively activating mutation in the third transmembrane helix of the luteinizing hormone receptor causes sporadic male gonadotropin independent precocious puberty
26. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors
27. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density
28. Differential expression of the β-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: A quantitative evaluation
29. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor
30. Constitutive activation of G protein coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III
31. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty
32. Constitutive activity of native thyrotropin-releasing hormone receptors revealed using a protein kinase C-responsive reporter gene
33. Theoretical study on mutation-induced activation of the luteinizing hormone receptor
34. 2-adrenergic receptor: Extending the ternary complex model
35. Constitutive activation of a single effector pathway: Evidence for multiple activation states of a G protein-coupled receptor
36. 1-adrenergic receptor activation
37. Crystal structure of rhodopsin: A G protein-coupled receptor
38. The functional topography of transmembrane domain 3 of the m1 muscarinic acetylcholine receptor, revealed by scanning mutagenesis
39. C5a receptor activation: Genetic identification of critical residues in four transmembrane helices
40. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin
41. Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoreceptor
42. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F
43. Similar structures and shared switch mechanisms of the b2-adrenoceptor and the parathyroid hormone receptor: Zn(II) bridges between helices III and VI block activation
44. Ca2+ mobilization by the LH receptor expressed in Xenopus oocytes independent of 3′,5′-cyclic adenosine monophosphate formation: Evidence for parallel activation of two signaling pathways
45. The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals
46. Removal of the surface-bound human choriogonadotropin results in the cessation of hormonal responses in cultured Leydig tumor cells
47. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the lutropin/choriogonadotropin receptor
48. Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cells
49. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
50. Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension
51. High-efficiency transformation of mammalian cells by plasmid DNA
52. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological dose-response curves
53. The inositol phosphate/diacylglycerol pathway in MA-10 Leydig tumor cells. Activation by arginine vasopressin and lack of effect of epidermal growth factor and human choriogonadotropin
54. Adenylate cyclase assay
55. Role of the rate of internalization of the agonist-receptor complex on the agonist-induced down-regulation of the lutropin/choriogonadotropin receptor
56. Internalization and degradation of receptor-bound human choriogonadotropin in Leydig tumor cells. Fate of the hormone subunits
57. The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis